Navegar

Colección

Datos Estadísticas

Lista de

T cell lymphoma
13
"The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies" (2016) Sterle, H.A.;Barreiro Arcos, M.L.;Valli, E. (...)Cremaschi, G.A. Journal of Molecular Medicine. 94(4):417-429
"The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies" (2016) Sterle, H.A.;Barreiro Arcos, M.L.;Valli, E. (...)Cremaschi, G.A. Journal of Molecular Medicine. 94(4):417-429
"The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies" (2016) Sterle, H.A.;Barreiro Arcos, M.L.;Valli, E. (...)Cremaschi, G.A. Journal of Molecular Medicine. 94(4):417-429
"Thyroid hormones and their membrane receptors as therapeutic targets for T cell lymphomas" (2016) Cremaschi, G.A.;Cayrol, F.;Sterle, H.A. (...)Barreiro Arcos, M.L. Pharmacological Research. 109:55-63
"Thyroid hormones and their membrane receptors as therapeutic targets for T cell lymphomas" (2016) Cremaschi, G.A.;Cayrol, F.;Sterle, H.A. (...)Barreiro Arcos, M.L. Pharmacological Research. 109:55-63
"Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways" (2016) Rabinovich, G.A.; Conejo-García, J.R. Journal of Molecular Biology. 428(16):3266-3281
"Classical and non-classical thyroid hormone intracellular pathways involved in T lymphoma growth" (2015) Arcos, M.L.B.;Sterle, H.;Cayrol, F. (...)Cremaschi, G.A. Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry. 15(1):37-42
"Thyroid status modulates T lymphoma growth via cell cycle regulatory proteins and angiogenesis" (2014) Sterle, H.A.;Valli, E.;Cayrol, F. (...)Barreiro Arcos, M.L. Journal of Endocrinology. 222(2):243-255
"Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment" (2014) Croci, D.O.;Cerliani, J.P.;Pinto, N.A. (...)Rabinovich, G.A. Glycobiology. 24(12):1283-1290
"The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide" (2012) Zacarías Fluck, M.F.;Hess, L.;Salatino, M. (...)Scharovsky, O.G. Cancer Immunology, Immunotherapy. 61(4):469-480
"1,2,4-Triazole d-ribose derivatives: Design, synthesis and antitumoral evaluation" (2012) Avanzo, R.E.;Anesini, C.;Fascio, M.L. (...)D'Accorso, N.B. European Journal of Medicinal Chemistry. 47(1):104-110
"Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas" (2009) Labeur, M.; Paez-Pereda, M.; Arzt, E.; Stalla, G.K. Reviews in Endocrine and Metabolic Disorders. 10(2):103-109
"Chronic restraint stress impairs T-cell immunity and promotes tumor progression in mice" (2009) Frick, L.R.;Barreiro Arcos, M.L.;Rapanelli, M. (...)Cremaschi, G.A. Stress. 12(2):134-143